Technical Analysis for MBGRF - Moberg Derma Ab

Grade Last Price % Change Price Change
grade A 7.55 4.14% 0.3000
MBGRF closed up 4.14 percent on Wednesday, October 9, 2019, on 1.83 times normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical MBGRF trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week High Strength 0.00%
Gapped Up Strength 0.00%
New 52 Week Closing High Bullish 4.14%
Narrow Range Bar Range Contraction 4.14%
New 52 Week High Strength 4.14%
Gapped Up Strength 4.14%
New 52 Week Closing Low Bearish 8.87%
Hot IPO Pullback Bullish Swing Setup 8.87%

Older signals for MBGRF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Moberg Pharma AB (publ), a pharmaceutical company, develops and sells medical products. The company provides Nalox/Naloc to treat discolored and deformed nails; Kerasal Nail, a product for fungus-damaged nails; Emtrix, a solution to treat discolored and deformed nails resulting from fungal infection or psoriasis; Kerasal foot ointment for dry feet and cracked heels; and Balmex, for reducing diaper rash. It also offers Balmex Adult Care rash cream for skin irritation and rash; Balmex, multi-purpose healing ointment; Domeboro for minor skin irritations; Dermoplast, a fast relief spray for pain and itching; and New Skin, a waterproof liquid bandage. In addition, the company develops MOB-015, which is under Phase III clinical trial for onychomycosis; and BUPI, a bupivacaine lozenge to treat pain due to oral mucositis in cancer patients. It markets its products directly in the United States, as well as through a network of distributors in approximately 40 countries. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was founded in 2006 and is headquartered in Bromma, Sweden.
RTT Cancer Pharmaceutical Pain Organ Systems Psoriasis Dermatology Cutaneous Conditions Oral Mucositis
Is MBGRF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.55
52 Week Low 6.9351
Average Volume 4,200
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.5500
Resistance 3 (R3) 7.5500 7.5500 7.5500
Resistance 2 (R2) 7.5500 7.5500 7.5500 7.5500
Resistance 1 (R1) 7.5500 7.5500 7.5500 7.5500 7.5500
Pivot Point 7.5500 7.5500 7.5500 7.5500 7.5500
Support 1 (S1) 7.5500 7.5500 7.5500 7.5500 7.5500
Support 2 (S2) 7.5500 7.5500 7.5500 7.5500
Support 3 (S3) 7.5500 7.5500 7.5500
Support 4 (S4) 7.5500